Literature DB >> 26105052

Sialic Acids on Varicella-Zoster Virus Glycoprotein B Are Required for Cell-Cell Fusion.

Tadahiro Suenaga1, Maki Matsumoto2, Fuminori Arisawa3, Masako Kohyama2, Kouyuki Hirayasu2, Yasuko Mori4, Hisashi Arase5.   

Abstract

Varicella-zoster virus (VZV) is a member of the human Herpesvirus family that causes varicella (chicken pox) and zoster (shingles). VZV latently infects sensory ganglia and is also responsible for encephalomyelitis. Myelin-associated glycoprotein (MAG), a member of the sialic acid (SA)-binding immunoglobulin-like lectin family, is mainly expressed in neural tissues. VZV glycoprotein B (gB) associates with MAG and mediates membrane fusion during VZV entry into host cells. The SA requirements of MAG when associating with its ligands vary depending on the specific ligand, but it is unclear whether the SAs on gB are involved in the association with MAG. In this study, we found that SAs on gB are essential for the association with MAG as well as for membrane fusion during VZV infection. MAG with a point mutation in the SA-binding site did not bind to gB and did not mediate cell-cell fusion or VZV entry. Cell-cell fusion and VZV entry mediated by the gB-MAG interaction were blocked by sialidase treatment. N-glycosylation or O-glycosylation inhibitors also inhibited the fusion and entry mediated by gB-MAG interaction. Furthermore, gB with mutations in N-glycosylation sites, i.e. asparagine residues 557 and 686, did not associate with MAG, and the cell-cell fusion efficiency was low. Fusion between the viral envelope and cellular membrane is essential for host cell entry by herpesviruses. Therefore, these results suggest that SAs on gB play important roles in MAG-mediated VZV infection.
© 2015 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  N-linked glycosylation; O-linked glycosylation; herpesvirus; membrane fusion; myelin-associated glycoprotein (MAG); sialic acid; sialic acid-binding immunoglobulin-type lectin 4 (Siglec-4); varicella-zoster virus (VZV); virus entry

Mesh:

Substances:

Year:  2015        PMID: 26105052      PMCID: PMC4528143          DOI: 10.1074/jbc.M114.635508

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  62 in total

1.  Myelin-associated glycoprotein interacts with ganglioside GT1b. A mechanism for neurite outgrowth inhibition.

Authors:  M Vinson; P J Strijbos; A Rowles; L Facci; S E Moore; D L Simmons; F S Walsh
Journal:  J Biol Chem       Date:  2001-03-06       Impact factor: 5.157

2.  Different functional domains in the cytoplasmic tail of glycoprotein B are involved in Epstein-Barr virus-induced membrane fusion.

Authors:  K M Haan; S K Lee; R Longnecker
Journal:  Virology       Date:  2001-11-10       Impact factor: 3.616

3.  Varicella-zoster virus infection of a human CD4-positive T-cell line.

Authors:  L Zerboni; M Sommer; C F Ware; A M Arvin
Journal:  Virology       Date:  2000-05-10       Impact factor: 3.616

Review 4.  Varicella-zoster virus: molecular virology and virus-host interactions.

Authors:  A M Arvin
Journal:  Curr Opin Microbiol       Date:  2001-08       Impact factor: 7.934

5.  Fibronectin is a binding partner for the myelin-associated glycoprotein (siglec-4a).

Authors:  K Strenge; R Brossmer; P Ihrig; R Schauer; S Kelm
Journal:  FEBS Lett       Date:  2001-06-22       Impact factor: 4.124

6.  Human herpesvirus 8 glycoprotein B (gB), gH, and gL can mediate cell fusion.

Authors:  Peter E Pertel
Journal:  J Virol       Date:  2002-05       Impact factor: 5.103

7.  Structural implications of Siglec-5-mediated sialoglycan recognition.

Authors:  Marina A Zhuravleva; Kathryn Trandem; Peter D Sun
Journal:  J Mol Biol       Date:  2007-10-11       Impact factor: 5.469

8.  Metabolic labeling of glycans with azido sugars and subsequent glycan-profiling and visualization via Staudinger ligation.

Authors:  Scott T Laughlin; Carolyn R Bertozzi
Journal:  Nat Protoc       Date:  2007       Impact factor: 13.491

9.  Functional roles of terminal glycomoieties in varicella-zoster virus infection.

Authors:  S Matsui; T Okuno; K Shiraki
Journal:  Virology       Date:  1994-01       Impact factor: 3.616

Review 10.  Virus glycosylation: role in virulence and immune interactions.

Authors:  David J Vigerust; Virginia L Shepherd
Journal:  Trends Microbiol       Date:  2007-03-29       Impact factor: 17.079

View more
  12 in total

1.  Immunogenicity of varicella zoster virus glycoprotein E DNA vaccine.

Authors:  Lidao Bao; Guomin Wei; Hongmei Gan; Xianhua Ren; Ruilian Ma; Y I Wang; Haijun Lv
Journal:  Exp Ther Med       Date:  2016-02-19       Impact factor: 2.447

2.  The Glycoprotein B Cytoplasmic Domain Lysine Cluster Is Critical for Varicella-Zoster Virus Cell-Cell Fusion Regulation and Infection.

Authors:  Edward Yang; Ann M Arvin; Stefan L Oliver
Journal:  J Virol       Date:  2016-12-16       Impact factor: 5.103

3.  Varicella-Zoster Virus Glycoproteins: Entry, Replication, and Pathogenesis.

Authors:  Stefan L Oliver; Edward Yang; Ann M Arvin
Journal:  Curr Clin Microbiol Rep       Date:  2016-09-09

4.  Varicella-zoster virus: molecular controls of cell fusion-dependent pathogenesis.

Authors:  Stefan L Oliver; Momei Zhou; Ann M Arvin
Journal:  Biochem Soc Trans       Date:  2020-12-18       Impact factor: 5.407

5.  The Structures and Functions of VZV Glycoproteins.

Authors:  Stefan L Oliver
Journal:  Curr Top Microbiol Immunol       Date:  2021-11-04       Impact factor: 4.737

6.  Global Mapping of O-Glycosylation of Varicella Zoster Virus, Human Cytomegalovirus, and Epstein-Barr Virus.

Authors:  Ieva Bagdonaite; Rickard Nordén; Hiren J Joshi; Sarah L King; Sergey Y Vakhrushev; Sigvard Olofsson; Hans H Wandall
Journal:  J Biol Chem       Date:  2016-04-15       Impact factor: 5.157

Review 7.  Possible Influences of Endogenous and Exogenous Ligands on the Evolution of Human Siglecs.

Authors:  Takashi Angata
Journal:  Front Immunol       Date:  2018-12-04       Impact factor: 7.561

8.  Global aspects of viral glycosylation.

Authors:  Ieva Bagdonaite; Hans H Wandall
Journal:  Glycobiology       Date:  2018-07-01       Impact factor: 4.313

9.  A glycoprotein B-neutralizing antibody structure at 2.8 Å uncovers a critical domain for herpesvirus fusion initiation.

Authors:  Stefan L Oliver; Yi Xing; Dong-Hua Chen; Soung Hun Roh; Grigore D Pintilie; David A Bushnell; Marvin H Sommer; Edward Yang; Andrea Carfi; Wah Chiu; Ann M Arvin
Journal:  Nat Commun       Date:  2020-08-18       Impact factor: 14.919

10.  Calcineurin phosphatase activity regulates Varicella-Zoster Virus induced cell-cell fusion.

Authors:  Momei Zhou; Vivek Kamarshi; Ann M Arvin; Stefan L Oliver
Journal:  PLoS Pathog       Date:  2020-11-20       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.